FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
Federal officials approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with ...
Each year, about 125 million opioid prescriptions are written for Americans with pain caused by broken bones, burns, ...
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...
The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.
The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks associated with ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of ...